{"result": "(\"entity\"<|>NUTRICIÓN PEDIÁTRICA<|>EVENT<|>NUTRICIÓN PEDIÁTRICA refers to the field of pediatric nutrition, focusing on the dietary needs and nutritional support for infants and children, particularly those who are critically ill or have specific medical conditions.)\n##\n(\"entity\"<|>D-GLUCOSA<|>ORGANIZATION<|>D-glucosa is a carbohydrate used in parenteral nutrition, responsible for a significant portion of the osmolarity of the solution and providing energy to patients.)\n##\n(\"entity\"<|>GLUCOSA<|>ORGANIZATION<|>Glucosa is a simple sugar that is a primary source of energy for the body, particularly important in medical nutrition for patients with specific dietary needs.)\n##\n(\"entity\"<|>INSULINA<|>ORGANIZATION<|>Insulina is a hormone that regulates glucose levels in the blood and is used in medical treatment to manage hyperglycemia in critically ill patients.)\n##\n(\"entity\"<|>RNPT<|>PERSON<|>RNPT refers to premature newborns who are particularly susceptible to glucose imbalances and require careful nutritional management.)\n##\n(\"relationship\"<|>NUTRICIÓN PEDIÁTRICA<|>D-GLUCOSA<|>D-glucosa is a key component in pediatric nutrition solutions, providing essential energy for infants and children<|>8)\n##\n(\"relationship\"<|>NUTRICIÓN PEDIÁTRICA<|>GLUCOSA<|>Glucosa is crucial in the context of pediatric nutrition, especially for energy provision in medical settings<|>8)\n##\n(\"relationship\"<|>NUTRICIÓN PEDIÁTRICA<|>INSULINA<|>Insulina is used to manage glucose levels in pediatric patients receiving nutritional support<|>7)\n##\n(\"relationship\"<|>NUTRICIÓN PEDIÁTRICA<|>RNPT<|>RNPT are a specific group of patients within pediatric nutrition that require tailored nutritional strategies<|>9)\n##\n(\"relationship\"<|>D-GLUCOSA<|>GLUCOSA<|>D-glucosa is a form of glucosa used in medical nutrition, highlighting its importance in energy provision<|>6)\n##\n(\"relationship\"<|>RNPT<|>GLUCOSA<|>RNPT require careful management of glucosa levels to avoid complications such as hypoglycemia and hyperglycemia<|>8)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: y 75% de glucosa, con el fin de reducir el riesgo de enfermedad hepática asociada al fracaso intestinal; reservando porcentajes más altos de lípidos para algunas situaciones excepcionales de alta demanda energética o intolerancia hidrocarbonada21. Por otra parte, en circunstancias de estrés elevado, la relación kcal no proteicas/gramos de nitrógeno puede ser más baja, de hasta 100/1 a 130/1.\n\n## 5. Composición de las soluciones de nutrición parenteral\n\n### 5.1. Hidratos de carbono\n\nLa D-glucosa es el hidrato de carbono empleado en la NP. Es responsable en gran parte, de la osmolaridad de la solución. Cuando se administra por vía periférica su concentración no debe sobrepasar el 10%-12%. Su aporte no debe exceder el 60-75% de las calorías no proteicas (50% kcal totales) y debe ser progresivo para evitar la hiperglucemia y la diuresis osmótica. La D-glucosa aporta 4 kcal/g (3,4 kcal/g en su forma anhidra). Las necesidades van a variar en función de la edad y de la condición clínica, aunque los aportes han de ser suficientes para cubrir las necesidades de consumo de glucosa del cerebro y no superar su capacidad oxidativa máxima. Como orientación, se recomienda comenzar en el neonato con 4-6 mg/kg/min (6-8 g/kg/día) y en el resto de edades con 5-7 mg/kg/min (7-10 g/kg/día), aumentando progresivamente 1-2 mg/kg/min/día hasta alcanzar el objetivo. La cantidad máxima recomendada es de 12 mg/kg/min (18 g/kg/día), siendo variable en función de la edad (tabla 4). En el caso de pacientes críticos, se aconseja utilizar un ritmo máximo de infusión de glucosa de 5 mg/kg/min (7,2 g/kg/día). En la fase aguda de la enfermedad crítica existe una marcada resistencia a la insulina, como consecuencia de las alteraciones endocrino-metabólicas que se producen.\n\n| Tabla 4. Requerimientos de glucosa en la nutrición parenteral según la edad. |\n|-----------------------------------------------------------------------------|\n\n| Edad | Dosis inicial: mg/kg/min g/kg/día | Dosis máxima: mg/kg/min g/kg/día |\n|------|-----------------------------------|----------------------------------|\n| Recién nacido pretérmino | 4-8 6-12 | 11-12 16-18 |\n| Lactantes y niños hasta 2 años | 5-7 7-10 | 11-12 16-18 |\n| Resto de edades | 3-5 4-7 | 8-10 10-14 |\n---\n866      BLOQUE: NUTRICIÓN PEDIÁTRICA\n\nademás, la producción endógena de glucosa es capaz de suplir el 20-50% del GET. Por ello, los requerimientos de glucosa en estos pacientes y, especialmente, en la fase inicial de la enfermedad, son sustancialmente inferiores a los habituales. Por último, hemos de tener en cuenta que los RNPT son muy susceptibles tanto a la hipoglucemia como a la hiperglucemia.\n\nEn el caso de que se cicle la NP, se recomienda no sobrepasar un ritmo de infusión de 1,2 g/kg/h, que corresponde a la tasa máxima de oxidación de la glucosa; así como realizar un ascenso y descenso progresivo del ritmo al inicio y al final de la infusión con el fin de evitar hipoglucemias o hiperglucemias12.\n\nUn aporte excesivo de glucosa puede producir hiperglucemia. La hiperglucemia se ha asociado a mayor mortalidad y aumento del riesgo de infección en el paciente gravemente enfermo22. El objetivo es intentar mantener el nivel de glucemia en estos pacientes por debajo de 150 mg/dl. En caso de cifras mantenidas por encima de 180 mg/dl se recomienda iniciar tratamiento con insulina. Otras consecuencias prejudiciales del aporte excesivo de glucosa son: diuresis osmótica y mayor retención hídrica, mayor producción de CO2, con incremento del cociente respiratorio (VCO2/VO2) que puede contribuir al deterioro de la función pulmonar y aumento del riesgo de esteatosis hepática23. Se recomienda, además, administrar los lípidos conjuntamente con la glucosa siempre que sea posible.\n\n## 5.2. Lípidos\n\nLos lípidos deben formar parte de las soluciones de NP por su elevada densidad calórica, por ser fuente de ácidos grasos esenciales, por disminuir la osmolaridad de la solución y por evitar los efectos negativos de la sobrecarga de glucosa. Además, se ha demostrado que su adición a la NP mejora el balance de nitrógeno24. Se recomienda que constituyan del\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}